Join us for the third installment of the Hot Topics in Lung Cancer series, highlighting the transformative potential of antibody-drug conjugates (ADCs) in the treatment of non-small cell lung cancer (NSCLC). In this live webinar, experts will provide an overview of the rapidly evolving ADC landscape, review pivotal clinical trial evidence, and discuss strategies for identifying patients most likely to benefit from ADCs. Don’t miss the 2D animation demonstrating the mechanisms of action of ADCs and illustrating how these agents precisely target NSCLC tumors.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/targeting-success-nsclc-emerging-role-antibody-drug-conjugates
- Start Date: 2025-04-24 05:00:00
- End Date: 2025-04-24 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: astrazeneca-pharmaceuticals - Amount: 0.0 - Is Kind Support: False Source: daiichi-sankyo,-inc - Amount: 0.0 - Is Kind Support: False Source: lilly-usa-llc - Amount: 0.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest